Objectives: The aim of this study was to assess the sensitivity and specificity of pseudo-continuous arterial spin labeling (PCASL) magnetic resonance angiography (MRA) with 3-dimensional (3D) radial acquisition for the detection of intracranial arteriovenous (AV) shunts. Materials and Methods: A total of 32 patients who underwent PCASL-MRA, clinical magnetic resonance imaging (MRI)/MRA exam, and digital subtraction angiography (DSA) were included in this retrospective analysis. Twelve patients presented with AV shunts. Among these were 8 patients with AV malformations (AVM) and 4 patients with AV fistulas (AVF). The clinical MRI/MRA included 3D time-of-flight MRA in all cases and time-resolved, contrast-enhanced MRA in 9 cases (6 cases with AV shunting). Research MRI and clinical MRI were independently evaluated by 2 neuroradiologists blinded to patient history. A third radiologist evaluated DSA imaging. A diagnostic confidence score was used for the presence of abnormalities associated with AV shunting (1-5). The AVMs were characterized using the Spetzler-Martin scale, whereas AVFs were characterized using the Borden classification. κ Statistics were applied to assess intermodality agreement. Conclusion: Noncontrast PCASL-MRA with 3D radial acquisition is a potential tool for the detection and characterization of intracranial AV shunts with a sensitivity and specificity equivalent or higher than routine clinical MRA.
C erebral arteriovenous malformations (AVMs) and arteriovenous fistulas (AVFs) are congenital or acquired direct communications between the arterial and venous circulations bypassing the capillary bed. Small AVMs and AVFs can be challenging to diagnose with noninvasive imaging. Therefore, digital subtraction angiography (DSA) remains the gold standard in the diagnosis and grading of such lesions owing to its high spatial and temporal resolution. A number of studies have evaluated different magnetic resonance angiography (MRA) techniques for the diagnosis and evaluation of AVMs and AVFs. Among these, 3-dimensional (3D) time-of-flight (ToF) has shown to be a sensitive, noncontrast technique. 1, 2 However, a subset of AVFs and small AVMs may not be visualized because of in-plane saturation and the lack of temporal dynamics. 3 Higher sensitivity and specificity and better characterization have been achieved with dynamic contrast-enhanced (CE) MRA. [3] [4] [5] [6] [7] However, dynamic CE-MRA fails to match the temporal resolution provided by DSA and there are potential safety concerns associated with gadolinium deposition in the deep brain nuclei. Highly sensitive and specific noncontrast MRA techniques would be beneficial for diagnosis and assessment of suspected AVMs and AVFs.
Arterial spin labeling (ASL) is a noncontrast magnetic resonance imaging (MRI) technique that can be applied for perfusion as well as angiographic imaging. 8, 9 Arterial spin labeling allows for reduced inflow effects compared with ToF and higher effective temporal resolution compared with CE-MRA. Arterial spin labeling techniques designed for perfusion have been found useful in detecting and grading AVMs and AVFs. [10] [11] [12] In these studies, ASL images collected with inherently low spatial resolution were shown to increase the sensitivity and specificity in the detection of arteriovenous (AV) shunting when applied as an adjunct to a clinical magnetic resonance (MR) examination. However, ASL perfusion sequences do not provide angiographic information and thus could not serve as a standalone sequence for the detection and grading of pathologies with AV shunting. Arterial spin labeling sequences designed for MRA have been refined since their introduction by Dixon et al, 13 with substantial improvements in image quality and spatial resolution. 14, 15 In particular, 3D volumetric pseudo-continuous ASL (PCASL)-MRA sequences with a high spatial resolution and comparable image quality to ToF-MRA have been developed. 16, 17 This technique has further been shown feasible to image AVMs [18] [19] [20] as static, but also time resolved noncontrast MRA. 21 The purpose of this work is to evaluate the sensitivity and specificity of an accelerated PCASL-based 3D MRA technique that uses a 3D radial acquisition technique in the detection and grading of cerebrovascular pathologies with AV shunting. The diagnostic efficacy of PCASL-MRA was compared with that of standard clinical MRI including MRA examination. In all cases, DSA served as a reference standard.
MATERIALS AND METHODS

Study Population
This study was Health Insurance Portability and Accountability Act compliant and approved by the local institutional review board. Written informed consent was obtained from all subjects.
A total of 32 subjects who were prospectively enrolled to undergo a research PCASL-MRA and had existing clinical MRA and DSA exams were included in this analysis. This cohort included 8 AVM and 4 AVF patients who did not receive treatment between DSA and both MRI exams. Of the remaining 20 patients, 10 presented with untreated aneurysms, 7 with treated aneurysms, 1 with high-grade middle cerebral artery stenosis, 1 with ischemic infarction, and 1 with microhemorrhages. The patients without AV shunting were included as a negative control group. The mean age of the patient group with AV shunting was 58.5 years (range, 41-75 years), with a female/male ratio of 5:7. The mean age of the negative control group was 59.7 years (range, 37-80 years), with a female/male ratio of 15:5. Patient characteristics are summarized in Table 1 .
Imaging Methods
Pseudo-Continuous Arterial Spin Labeling
All PCASL-MRA scans were performed at 3 T (Discovery MR 750w, GE Healthcare, Waukesha, WI). To avoid off-resonance artifacts that are a particular issue in intracranial applications of PCASL due to susceptibility at the skull base and nasal fossa, the acquisition module consists of a low flip angle spoiled gradient readout combined with an undersampled 3D radial sampling strategy. The PCASL acquisition has been described in detail (blinded for review).
The PCASL vastly undersampled isotropic-voxel radial projection imaging parameters include the following: labeling duration, 3 seconds; image acquisition window, 1 second; field of view, 22 Â 22 Â 16 cm 3 ; 3D isotropic resolution, 0.68 mm; readout bandwidth, ±62.50 kHz; repetition time/echo time = 5.06/1.07 milliseconds; fractional echo, 0.75; flip angle, 10°; no flow compensation. A total of 12,000 projections were collected in a scan time of 8 minutes 27 seconds. Compared with Nyquist, this represents a Â13 undersampling. Data acquired for the label image and control image are first subtracted in k-space then reconstructed using an optimized gridding routine 22 zero-filled to 0.46 mm isotropic resolution. Individual coil images were combined using coil sensitivities estimated from low-resolution unsubtracted images. 23 
Clinical MRA
Of the 32 subjects, 14 (44%) were scanned at a field strength of 1.5 T (Signa HDxt/Optima MR 450w, GE Healthcare) and 18 (56%) at 3 T (Discovery MR 750/Discovery MR 750w, GE Healthcare). All examinations included the following sequences: 3D ToF-MRA (spatial resolution: 3 T: 0.7 mm Â 0.6 mm Â 0.7 mm; 1.5 T: 0.7 mm Â 0.8 mm Â 1.4 mm, axial/3D gradient-echo T1w, axial T2w fast spin echo, 3D fluid attenuated inversion recovery and axial diffusion weighted imaging). In addition, 17 (55%) underwent CE 3D MRA (spatial resolution: 3 T: 0.7 mm Â 0.8 mm Â 1.6 mm; 1.5 T: 0.7 Â 0.8 Â 1.6 mm) and 9 underwent time-resolved CE-MRA (spatial resolution: 3 T: 0.8 mm Â 0.9 mm Â 2 mm; 1.5 T: 0.8 mm Â 1 mm Â 3 mm). Among the 12 patients with AVMs and AVFs, 6 were scanned at 1.5 T, and 6, at 3 T. Among the 12 patients with AVMs and AVFs, 11 received CE gradient echo T1w and 10 underwent CE 3D MRA; among those, 6 patients had a time-resolved CE-MRA.
DSA Examination
All DSA examinations were obtained using an Artis Zee biplane system (Siemens Healthcare, Erlangen, Germany). The biplane DSA acquisitions were obtained with temporal resolution ranging from a minimum of 2 to 6 frames per second in standard projections with injections in both internal carotid arteries and at least 1 vertebral artery. Hand injections were used for 2D projections and a power injector was applied for 3D rotational DSA.
Image Analysis
The PCASL-MRA images and clinical MRAs were evaluated independently in random order by 2 neuroradiologists (with more than 25 and 9 years' experience, respectively), blinded to patient history and identity. Research and clinical images were evaluated in 2 separate sessions 4 weeks apart to avoid bias due to case recognition. A PACS workstation was used for image analysis (McKesson, San Francisco, CA). A separate reader with 4 years of experience in DSA imaging evaluated all DSA exams. The DSA reader had access to all clinical and imaging information. He used the DSA imaging data as well as the DSA report composed by a staff neurointervenionist to report the Spetzler-Martin score or the Borden score.
An electronic evaluation form was applied by using a "drilldown" methodology in which specific aspects of the imaging modality and vascular pathology (if any) were answered on the basis of the evaluator's previous selections. For example, for the vascular malformation cases, the form took the evaluator through the pertinent questions starting with the presence or absence of an abnormality and, if present, which type of abnormality and then a series of morphologic and measurement questions to determine the clinical grade. Study data were collected and managed by using Research Electronic Data Capture electronic data capture tools (https://catalyst.harvard.edu/services/redcap/) with grant support (Clinical and Translational Science Award program, through the National Institutes of Health National Center for Advancing Translational Sciences, grant UL1TR000427). 24 During the assessment of the clinical MRA exam, readers were allowed to review all available imaging additional to the MRA sequence (s) they found useful for the evaluation of the case.
The evaluation criteria included (1) venous signal in PCASL/ ToF-MRA or early venous signal if time-resolved CE-MRA available (yes/no); (2), diagnostic confidence of AV shunting present (1 = definitely not/2 = probably not/3 = unsure/4 = probably yes/5 = definitely yes); (3) type of abnormality (AVM/AVF); and (4) image quality PCASL/ToF-MRA (5-point scale: 1 = not interpretable to 5 excellent).
For AVM grading, evaluation criteria included location, size (x/y/z), number or arterial feeders (main branches), number of draining veins, location of draining veins (superficial/deep), and SpetzlerMartin score. 25 For AVF grading, evaluation criteria included presence of cortical venous reflux (y/n), number or arterial feeders (main branches), and Borden classification. 26 
Statistical Analysis
To assess the validity of using the PCASL-MRA or clinical MRA result in diagnosing either AVM or AVF, the specificity, sensitivity, positive predictive value (PPV), and negative predictive value (NPV) were calculated. These probabilities are listed for each reader, separated by their use of either PCASL-MRA or clinical MRA. The DSA results are considered the truth when assessing the subject's diagnosis.
Upon identifying cases of AVM and AVF, the level of agreement between each reader and DSA for Spetzler-Martin score (AVMs) and Borden classification (AVFs) was calculated using the κ statistics.
Number of arterial feeders and draining veins were analyzed using the median and interquartile range (IQR).
κ Statistics can range from −1 to 1, with 0 indicating random guessing and +1 indicating 100% agreement. Statistical significance of κ statistics is widely debated and is generally not presented in papers. Figure 1 shows a representative case without AV shunting. No venous signal can be identified. The image exclusively shows the intracranial arteries as well as the branches of the external carotid arteries. Figure 2 shows a small, residual cerebellar AVM that was treated microsurgically 10 years earlier. The nidus is better delineated with PCASL-MRA compared with ToF-MRA because of the lack of inplane saturation effects. The nidus size and venous drainage are confirmed by DSA. Figure 3 illustrates a left sigmoid sinus AVF without symptoms at the time of MRI. Time of flight MRA visualized the feeding artery, but AV shunting was suspected to be absent or diminutive. The PCASL-MRA shows some residual AV shunting in the sigmoid sinus. A DSA exam before the MRAs shows the left sigmoid sinus AVF. Figure 4 shows an anterior cranial fossa AVF fed by branches originating from the ophthalmic artery. The PCASL-MRA, timeresolved CE-MRA, and DSA agree on the location and feeder of the fistula. This AVF could not be visualized with ToF-MRA. 
RESULTS
Sensitivity, Specificity, PPV, and NPV for the Diagnosis of AVMs and AVFs
Two PCASL-MRA cases were rated nondiagnostic by both reviewers accordingly. Both consisted of untreated aneurysms; the clinical MRA was diagnostic in both of the cases. These 2 cases were excluded from further analysis for both PCASL and clinical MRA.
Pseudo-Continuous Arterial Spin Labeling MRA
Of 12 cases with AV shunting, 12 were correctly identified by reader 1 (8 AVMs, 4 AVFs) and 11 were correctly identified by reader 2 (7 AVMs, 4 AVFs). One AVM case was rated false-negative by reader 2. Of 18 cases without AV shunting, 18 were correctly identified as negative for AV shunting by both readers. This leads to a sensitivity of 100% and a specificity of 100% for reader 1 and a sensitivity of 91.7% and a specificity of 100% for reader 2 for the diagnosis of AV shunts. The PPV/NPV was 100%/100% for reader 1 and 100%/ 94.7% for reader 2.
Venous signal was reported in 12 of 30 cases (reader 1) and 11 out of 30 cases (reader 2). All of these patients were confirmed with AVMs or AVFs. Both readers reported no venous signal in 18 control cases. Average score of diagnostic confidence of AV shunting present was 4.8 (reader 1) and 4.66 (reader 2) in all confirmed cases with AVMs and AVFs. Average diagnostic confidence scores were 1.15 for both readers in the control group. Average score for image quality was rated 4.0 by reader 1 and 4.4 by reader 2.
Clinical MRA
Of 12 cases with AV shunting, 11 were correctly identified by both readers (7 AVMs, 4 AVFs). One AVM case was rated falsenegative by both readers. One case was rated false-positive with a carotid-cavernous AV fistula by reader 1. Of 18 cases, 17 were correctly identified as negative for AV shunting by reader 1 and 18 by reader 2. This leads to a sensitivity of 91.7% and a specificity of 94.4% for reader 1 and a sensitivity of 91.7% and a specificity of 100% for reader 2 for the diagnosis of AV shunts. The PPV/NPV was 91.7%/94.7% for reader 1 and 100%/94.7% for reader 2.
Venous signal in ToF-MRA was reported in 13 of 30 cases for reader 1 and in 14 of 30 cases for reader 2. Of these cases, 10 for reader 1 and 11 for reader 2 were confirmed AVMs or AVFs. Venous signal in ToF-MRA was reported in 3 of 18 control cases by reader 1 and in 3 of 18 control cases by reader 2. The average score of diagnostic confidence of AV shunting present was 4.25 (reader 1) and 4.66 (reader 2) in all confirmed patients with AVMs and AVFs. Average diagnostic confidence scores were 1.15 (reader 1) and 1.2 (reader 2) in the control group. The average score for image quality of the ToF-MRA was rated 4 by reader 1 and 4.1 by reader 2. None of the ToF-MRAs were rated nondiagnostic. The sensitivity and specificity of both imaging modalities are summarized in Table 2 .
Based on DSA, 7 cases out of 12 with AV-shunts were identified as AVMs and 5 as AVFs. One posterior-fossa pathology initially reported as tentorial AVF was resected and found to be a small AVM. The ratings for this study were consistent across the DSA reader and the initial DSA report.
AVM Grading
Comparison Between PCASL-MRA and DSA 
AVF Classification
Comparison Between PCASL-MRA and DSA Scores for AVM and AVF and κ values are summarized in Table 3 .
DISCUSSION
In this study, we showed that high-resolution, noncontrast PCASL-MRA is an effective tool to detect and classify intracranial AV shunts. Pseudo-continuous ASL MRA proved to be as sensitive and specific as a full clinical MRA exam with multiple sequences, including a ToF-MRI, in all cases and a time-resolved CE-MRA in 50% of cases with AV shunting.
Several reports have shown the benefit of ASL and PCASL-MRA in the diagnosis of intracranial AV fistulas and AV malformations. 2, 6, 10, 12 However, the role of ASL was limited to an adjunct to a clinical MRI scan owing to the lack of angiographic information and the low spatial resolution in these studies. Further studies have shown the ability of noncontrast ASL MRA to properly visualize AVMs but did not evaluate the sensitivity and specificity. [18] [19] [20] 27 To our knowledge, this is the first report evaluating the sensitivity and specificity of high-resolution noncontrast PCASL-MRA alone to detect intracranial AV shunting.
Pseudo-continuous ASL is used for brain perfusion imaging and increasingly as a noncontrast MRA technique. 28, 29 In this technique, arterial spins are labeled and therefore can be imaged when travelling through the arterial tree. However, as soon as excited protons enter the capillary system, they undergo an exchange with water protons contained in the extracellular space. This leads to a rapid signal loss within the capillary bed and consecutively a highly specific display of the arterial system without venous contamination. However, if a direct communication between the arterial and the venous system exists, the labeled arterial spins are able to carry over signal into the venous vasculature. Therefore, venous signal in a PCASL angiogram is likely to reflect AV shunting with high specificity. Time-of-flight MRA and CE-MRA can perform with similar high sensitivity. However, there are more potential sources of venous contamination possible in ToF-MRA (veins entering the imaging slab in the same direction as arteries [i.e., skull base], suboptimal placement of saturation bands) and CE-MRA (primarily suboptimal bolus timing).
The excellent sensitivity and specificity in diagnosing intracranial AV shunts is reflected by the results of both readers, with reader 1 achieving a higher sensitivity and specificity than with a full clinical MRI exam.
For AVM characterization, agreement with DSA on SpetzlerMartin score was equivalent using PCASL-MRA or the clinical MRA for both readers. However, we could not reproduce the very high agreement on Spetzler-Martin classification reported for time-resolved PCASL-MRA. 20 For AVF characterization, agreement with DSA on Borden classification was higher using PCASL-MRA than the clinical MRA exam for both readers. The lower numbers of agreement in our study compared with the referenced study on AVMs may be a result of the low case numbers when ungrouping AVMs and AVFs for characterization. Additional advantages of PCASL-MRA are the lack of contrast agent, which allows high spatial resolution imaging compared with dynamic CE-MRA, where rapid imaging is necessary to capture the passing contrast bolus. Furthermore, the growing evidence of gadolinium deposition in the brain likely leads to a greater interest in contrast-free alternatives to CE-MRI. The used PCASL-MRA sequence provides consistent results, as shown by a low number of nondiagnostic scans in our study. This might be related to the 3D radial trajectory, which makes acquisitions less sensitive to patient motion and mitigates blurring from magnetization evolution through the readout. In addition, although the spoiled gradient readout provides lower overall signalto-noise ratio compared with alternative readouts, it is insensitive to off-resonance. This is especially important for AVFs and AVMs of the posterior fossa, where alternative readout strategies (i.e., balanced steady state free-precession) can suffer from macroscopic gradients in regions of large susceptibility changes. 18, 20 Especially for AVFs, which are frequently found in the posterior fossa close to the skull and fed by external carotid artery branches, this is an essential characteristic. Compared with PCASL-MRA, no nondiagnostic ToF-MRAs were observed in this study. This is most likely related to the shorter scan time but also smaller spatial coverage of the ToF-MRA.
Our study has several shortcomings. First, this was a retrospective study with potential unknown biases. Specifically, intracranial pathologies other than AVFs or AVMs might lead to negative bias in the sense of a satisfaction of search error. Second, most of the very subtle, small AV shunts in this study were located in the posterior, middle, and anterior cranial fossa. The location of small AVMs and AVFs in the apical cranial convexity might affect the sensitivity of PCASL-MRA as the labeled blood loses signal travelling the greater distance from the labeling plane. Further tailoring of the applied labeling delay could be used to optimize the sequence respective to small convexity AVMs. Finally, the clinical MRA exams were performed at different magnetic field strength with different MRA protocols. Consistent scanning at 3 T might improve sensitivity given the higher signal-to-noise ratio.
In conclusion, PCASL-MRA yields excellent results in the detection and moderate results in grading of cerebrovascular diseases with AV-shunting without the need for exogenous contrast agents in the present study. Due to the lack of special hardware, the utilized MR sequence could be applied on different MR scanner platforms.
